01.20.15
Biotec Services International, a PCI company, has completed validation of their clinical supply facility expansion, which adds almost 50% to the company’s clinical trial packaging, storage and distribution capacity.
The company increased refrigerated storage and packaging capacity by more than 400%, and more than doubled capacity to handle and store cell therapies and other advanced drug products. Additionally, the company has acquired land adjacent to its current site for future capacity and capability expansions.
Packaging Coordinators Inc. (PCI), a global provider of drug development services, acquired Biotec in September 2014 as part of ongoing investments in solutions for difficult development challenges, such as temperature-controlled packaging and distribution. The Biotec site specializes in the management of temperature-sensitive products, and has expertise in handling products at temperatures ranging from +25ºC down to -196ºC.
Dr. Fiona Withey, managing director, UK Clinical Services at PCI said, “Biotec’s business has grown as a result of our expertise in the packaging and distribution of temperature-sensitive biopharmaceutical products, and our ability to efficiently manage our clients’ projects regardless of their size. By increasing our temperature-controlled capacity, and designing flexibility into our operations, our recent investments illustrate our continued commitment to these key attributes of our business.”
The company increased refrigerated storage and packaging capacity by more than 400%, and more than doubled capacity to handle and store cell therapies and other advanced drug products. Additionally, the company has acquired land adjacent to its current site for future capacity and capability expansions.
Packaging Coordinators Inc. (PCI), a global provider of drug development services, acquired Biotec in September 2014 as part of ongoing investments in solutions for difficult development challenges, such as temperature-controlled packaging and distribution. The Biotec site specializes in the management of temperature-sensitive products, and has expertise in handling products at temperatures ranging from +25ºC down to -196ºC.
Dr. Fiona Withey, managing director, UK Clinical Services at PCI said, “Biotec’s business has grown as a result of our expertise in the packaging and distribution of temperature-sensitive biopharmaceutical products, and our ability to efficiently manage our clients’ projects regardless of their size. By increasing our temperature-controlled capacity, and designing flexibility into our operations, our recent investments illustrate our continued commitment to these key attributes of our business.”